Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PRA HEALTH SCIENCES, INC.

(PRAH)
  Report
 SummaryQuotesChartsNewsRatingsCompanyFinancials 
Estimated financial data (e) (USD)
Sales 2019 3 066 M - -
Net income 2019 243 M - -
Net Debt 2019 1 231 M - -
P/E ratio 2019 30,2x
Yield 2019 -
Sales 2020 3 183 M - -
Net income 2020 197 M - -
Net Debt 2020 967 M - -
P/E ratio 2020 41,3x
Yield 2020 -
Capitalization 10 705 M 10 705 M -
EV / Sales 2019 2,69x
EV / Sales 2020 2,83x
Nbr of Employees 18 100
Free-Float 100,0%
More Financials
Company
PRA Health Sciences, Inc. is a United States-based company. The Company is a contract research organization. It is engaged in providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. The Company focused on oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. It operates through two segments:... 
More about the company
Ratings of PRA Health Sciences, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about PRA HEALTH SCIENCES, INC.
2021MARKET CHATTER : Helixmith Chooses PRA Health Sciences for Phase Three Trials of Engensis
MT
2021ICON PUBLIC : Posts Higher Q2 Results from Year Ago, Updates Guidance -- Stock Down 3% Aft..
MT
2021PRA HEALTH SCIENCES : Mizuho Securities Starts PRA Health Sciences at Neutral with $169 Pr..
MT
2021PRA HEALTH SCIENCES, INC.(NASDAQGS : PRAH) dropped from S&P 400
CI
2021PRA HEALTH SCIENCES, INC.(NASDAQGS : PRAH) dropped from S&P 400 Health Care
CI
2021PRA HEALTH SCIENCES, INC.(NASDAQGS : PRAH) dropped from S&P Composite 1500
CI
2021PRA HEALTH SCIENCES, INC.(NASDAQGS : PRAH) dropped from S&P TMI Index
CI
2021PRA HEALTH SCIENCES, INC.(NASDAQGS : PRAH) dropped from S&P Global BMI Index
CI
2021PRA HEALTH SCIENCES, INC.(NASDAQGS : PRAH) dropped from S&P 1000
CI
2021PRA HEALTH SCIENCES : Senior Secured Credit Facilities (Form 8-K)
PU
2021PRA HEALTH SCIENCES : Completion of Acquisition or Disposition of Assets (Form 8-K)
PU
2021PRA HEALTH SCIENCES, INC. : Entry into a Material Definitive Agreement, Termination of a M..
AQ
2021PRA HEALTH SCIENCES, INC. : Completion of Acquisition or Disposition of Assets, Notice of ..
AQ
2021PRA Health Sciences, Inc. Announces Board Changes
CI
2021PRA Health Sciences, Inc.'s Equity Buyback announced on August 30, 2019, has expired.
CI
More news
News in other languages on PRA HEALTH SCIENCES, INC.
2021ICON affiche des résultats supérieurs à ceux de l'année précédente pour le deuxième tri..
2021PRA Health Sciences et Veradigm d'Allscripts prévoient un réseau de recherche clinique ..
2021ICON émet pour 500 millions de dollars d'obligations garanties de premier rang
2021Icon Unit va lever 2 milliards de dollars par le biais d'une offre d'obligations garant..
2021PRA Health Sciences innove dans la mise en relation des données des essais cliniques de..
More news
Analyst Recommendations on PRA HEALTH SCIENCES, INC.
More recommendations
Chart PRA HEALTH SCIENCES, INC.
Duration : Period :
PRA Health Sciences, Inc. Technical Analysis Chart | PRAH | US69354M1080 | MarketScreener
Income Statement Evolution
Managers and Directors
Kent Thoelke Chief Scientific Officer & Executive VP
Isaac Rodriguez-Chavez Senior VP-Scientific & Clinical Affairs
Tami Klerr-Naivar Chief Business Development & Marketing Officer
Samir Shah President-Strategic Solutions & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
PRA HEALTH SCIENCES, INC.0.00%10 965
MODERNA, INC.-38.07%63 777
LONZA GROUP AG-19.59%49 711
IQVIA HOLDINGS INC.-13.62%46 556
SEAGEN INC.-16.20%23 689
ICON PUBLIC LIMITED COMPANY-17.32%20 842